查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1494855

到 2030 年体外诊断实验室自动化市场预测：按产品、设备、技术、应用、最终用户和地区进行的全球分析

Lab Automation For In-Vitro Diagnostic Market Forecasts to 2030 - Global Analysis By Product, Equipment, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC的数据，2024年全球体外诊断实验室自动化市场规模为1,315.9亿美元，预计2030年将达到1,930.9亿美元，复合年增长率为6.60%。

体外诊断实验室自动化将彻底改变医学实验室的业务，透过优化工作流程来提高生产力。样品製备、分析和资料管理等任务将自动化，结合先进的机器人、软体和设备，以减少人为错误并提高吞吐量。借助这项技术，患者可以透过快速、准确的检测，更快地得到诊断并决定治疗方案。

根据美国临床化学协会 (AACC) 的说法，实验室自动化透过提高效率、减少错误并最终改善患者治疗结果，在现代医疗保健中发挥重要作用。

对高性能评估的需求不断增加

临床诊断、基因组学、药物发现和其他领域对高性能筛检(HTS) 技术的应用正在不断增长。 HTS 可用于快速筛检大型化合物库，以在药物发现过程中寻找潜在的候选药物。此外，次世代定序(NGS) 等 HTS 技术也有助于分析大量基因组资料，以用于基因组学领域的癌症基因组分析和个人化医疗等应用。

初始资本支出太多

实施实验室自动化系统需要在人力资源、软体、硬体和基础设施方面进行大量前期投资。对于实验室，尤其是预算紧张的小型实验室来说，机器人系统、液体处理工作站和整合实验室资讯管理系统 (LIMS) 等自动化平台的高成本可能会成为经济负担。此外，软体更新、校准和维护的持续成本进一步增加了总拥有成本，这可能会阻碍注重预算的公司采用该技术。

扩大照护现场(POCT)

照护现场检测 (POCT) 正在广泛应用于各种医疗机构，包括诊所、药房、医院和社区设施。这是由对分散测试解决方案和快速诊断服务不断增长的需求所推动的。此外，透过实现现场测试、即时结果交付和快速临床干预，POCT 设备、手持式分析仪、可携式诊断设备和基于智慧型手机的应用程式可以改善患者的结果，从而实现及时诊断和医疗保健结果。

市场饱和，竞争激烈

在竞争激烈的体外诊断实验室自动化市场中，许多全球公司、专业製造商和新兴企业提供了广泛的自动化解决方案和诊断测定。市场饱和，尤其是与激烈的价格竞争和自动化平台的商品化相结合，将对行业现有企业的利润和收益成长带来下行压力。此外，替代产品、颠覆性技术和新竞争对手的兴起增加了现有企业的压力，导致价格竞争、市场占有率下降和​​市场整合。

COVID-19 的影响：

体外诊断实验室自动化市场受到 COVID-19 大流行的重大影响，机会与挑战并存。儘管由于供应链中断、製造延误和医疗设施暂时关闭，疫情最初减缓了市场成长，但它加速了自动化技术的采用，以满足诊断测试需求的激增。此外，实验室自动化解决方案对于支援大流行应对工作以及透过提高检测能力、优化样本处理和缩短 COVID-19 检测的交付时间来实现经济的安全重新开放至关重要。

试剂和套件部分预计将在预测期内成为最大的部分

在体外诊断实验室自动化市场中，试剂和套件通常占据最大的市场占有率。这些必要的元素包括广泛的材料，例如诊断测试过程中使用的生物化学、抗体和探针。试剂和套件是许多测试的核心，从简单的血液分析到复杂的分子诊断。此外，它的普遍存在是由于对准确有效的测试方法的持续需求以及它在各种诊断应用中的必要性。

液体处理机领域预计在预测期内复合年增长率最高

在体外诊断实验室自动化市场中，自动液体处理机通常表现出最高的复合年增长率。自动化液体处理器简化了将试剂和样品等液体准确分配到不同容器、板和管中的过程。借助这项技术，实验室工作流程变得更有效率、准确和高效。此外，对更快、标准化诊断流程的需求不断增长，以及减少实验室业务中的错误和提高可重复性的需求正在推动自动化液体处理系统的广泛采用。

比最大的地区

体外诊断实验室自动化市场由北美主导。该地区较早采用最尖端科技，在研发方面投入大量资金，并拥有先进的医疗基础设施。市场领先的参与企业、支持性的政府政策以及对医学研究的资助都有助于北美在该行业的主导地位。此外，由于人口老化和慢性病的高盛行率，对有效和准确的诊断解决方案的需求不断增加。

复合年增长率最高的地区：

体外诊断实验室自动化市场预计将以亚太地区最高的复合年增长率成长。这种快速成长是由多种因素推动的，包括医疗成本上升、医疗基础设施的改善以及对先进诊断技术的日益重视。由于人口老化和慢性病盛行率上升，对有效、准确的诊断工具的需求不断增加。此外，该地区还受益于大量公共和私人健康投资以及旨在实现检测服务现代化的政府支援计划。

免费客製化服务：

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 按产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行概述

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第 5 章：全球体外诊断实验室自动化市场：按产品

  • 介绍
  • 试剂和套件
  • 装置
  • 资料管理软体
  • 其他的

第 6 章：全球体外诊断实验室自动化市场：依设备分类

  • 介绍
  • 自动板材处理机
  • 自动液体处理机
  • 机械臂
  • 自动仓储系统
  • 分析仪
  • 其他的

第 7 章：全球体外诊断实验室自动化市场：依技术分类

  • 介绍
  • 免疫检测/免疫化学
  • 临床化学
  • 血液学
  • 分子诊断
  • 微生物学
  • 凝血和止血
  • 尿液检查
  • 其他的

第八章全球体外诊断实验室自动化市场：依应用分类

  • 介绍
  • 感染疾病
  • 糖尿病
  • 药物测试/药物基因组学
  • 自体免疫疾病
  • 肿瘤学
  • 心臟病学
  • HIV/AIDS
  • 肾臟病学
  • 其他的

第 9 章：全球体外诊断实验室自动化市场：依最终使用者分类

  • 介绍
  • 医院检查室
  • 照护现场检测中心
  • 学术机构
  • 临床检验室
  • 病人
  • 其他的

第 10 章：全球体外诊断实验室自动化市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • Cognex Corporation
  • Quidel Corporation
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Chembio Diagnostics, Inc
  • Bio-Rad Laboratories, Inc.
  • Surmodics, Inc.
  • Danaher Corporation
  • Tecan Group Ltd
  • Sysmex Corporation
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
Product Code: SMRC26374

According to Stratistics MRC, the Global Lab Automation for In-Vitro Diagnostic Market is accounted for $131.59 billion in 2024 and is expected to reach $193.09 billion by 2030 growing at a CAGR of 6.60% during the forecast period. Medical laboratory operations are completely transformed by lab automation for in-vitro diagnostics, which increases productivity by optimizing workflows. Tasks like sample preparation, analysis, and data management are automated, lowering human error and boosting throughput by combining sophisticated robotics, software, and instrumentation. With the help of this technology, patients can receive a diagnosis and make treatment decisions more quickly thanks to rapid and accurate testing.

According to the American Association for Clinical Chemistry (AACC), laboratory automation plays a crucial role in modern healthcare by improving efficiency, reducing errors, and ultimately enhancing patient care outcomes.

Market Dynamics:

Driver:

Growing requirement for high-throughput evaluation

Clinical diagnostics, genomics, drug discovery, and other fields are finding increasing applications for high-throughput screening (HTS) techniques. With HTS, a large compound library can be quickly screened to find possible drug candidates in the drug discovery process. Moreover, the analysis of massive genomic data for uses like cancer genomics and personalized medicine is similarly made easier in the field of genomics by HTS technologies like next-generation sequencing (NGS).

Restraint:

Excessive initial capital outlay

Lab automation system implementation necessitates a large upfront investment in personnel training, software, hardware, and infrastructure. For laboratories, especially smaller ones with tighter budgets, the high cost of automation platforms such as robotic systems, liquid handling workstations, and integrated laboratory information management systems (LIMS) can be a financial burden. Furthermore, the total cost of ownership is further increased by continuing costs for software updates, calibration, and maintenance, which may discourage adoption among budget-conscious businesses.

Opportunity:

Point-of-care testing (POCT) expansion

Point-of-care testing (POCT) is becoming more widely used in a variety of healthcare settings, such as clinics, pharmacies, hospitals, and community-based facilities. This is due to the growing demand for decentralized testing solutions and quick diagnostic services. Moreover, by enabling on-site testing, real-time result delivery, and prompt clinical intervention, POCT devices, handheld analyzers, portable diagnostic instruments, and smart phone-based applications improve patient access to timely diagnosis and healthcare outcomes.

Threat:

Market Saturation and vigorous rivalry

A wide range of automation solutions and diagnostic assays are offered by a number of global players, specialized manufacturers, and start-ups in the fiercely competitive lab automation for in-vitro diagnostics market. Market saturation puts downward pressure on profit margins and revenue growth for industry incumbents, especially when combined with fierce price competition and the commoditization of automation platforms. Additionally, the rise of substitute products, disruptive technologies, and new competitors increases the pressure on existing ones, causing price wars, market share erosion, and market consolidation.

Covid-19 Impact:

The market for lab automation for in-vitro diagnostics has been significantly impacted by the COVID-19 pandemic, which has brought about both opportunities and challenges. Although the pandemic slowed market growth initially due to supply chain disruptions, manufacturing delays, and healthcare facilities temporarily closing, it also accelerated the adoption of automation technologies to meet the spike in demand for diagnostic testing. Furthermore, solutions for laboratory automation were essential in helping to support pandemic response efforts and enable the safe reopening of economies by increasing testing capacity, optimizing sample processing, and shortening turnaround times for COVID-19 testing.

The Reagents and Kits segment is expected to be the largest during the forecast period

Reagents and kits usually have the largest market share in the lab automation for in-vitro diagnostics market. These necessary elements include a broad range of materials, such as biochemical, antibodies, and probes that are utilized in diagnostic testing procedures. From simple blood analyses to intricate molecular diagnostics, reagents and kits are the cornerstone of many tests. Moreover, their ubiquity is attributed to their necessity in a variety of diagnostic applications as well as the ongoing need for precise and effective testing methods.

The Automated Liquid Handler segment is expected to have the highest CAGR during the forecast period

In the lab automation for in vitro diagnostic market, the automated liquid handler usually exhibits the highest CAGR. With the least amount of human involvement, automated liquid handlers simplify the process of precisely dispensing liquids-such as reagents and samples-into different containers, plates, or tubes. With the help of this technology, laboratory workflows can be made much more efficient, accurate, and productive. Additionally, the growing need for quicker and more standardized diagnostic processes, as well as the need to lower errors and enhance reproducibility in laboratory operations, are what are driving the increasing adoption of automated liquid handling systems.

Region with largest share:

The market for lab automation for in-vitro diagnostics is dominated by North America. The region's early adoption of cutting-edge technologies, substantial investment in research and development, and sophisticated healthcare infrastructure are all credited with its dominance. Leading market participants, supportive government policies, and financing for medical research all contribute to North America's dominant position in the industry. Furthermore, the need for effective and precise diagnostic solutions is fueled by the aging population and the high prevalence of chronic diseases.

Region with highest CAGR:

The lab automation for in-vitro diagnostic market is anticipated to grow at the highest CAGR in the Asia-Pacific region. Numerous factors, such as rising healthcare costs, growing healthcare infrastructure, and a growing emphasis on advanced diagnostic technologies, are responsible for this rapid growth. The need for effective and precise diagnostic tools is fueled by the aging population and the rising incidence of chronic diseases. Additionally, the area also gains from significant public and private healthcare investments, as well as from supportive government programs targeted at modernizing laboratory services.

Key players in the market

Some of the key players in Lab Automation For In-Vitro Diagnostic market include F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Cognex Corporation, Quidel Corporation, Abbott Laboratories, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Chembio Diagnostics, Inc, Bio-Rad Laboratories, Inc., Surmodics, Inc., Danaher Corporation, Tecan Group Ltd, Sysmex Corporation, Agilent Technologies Inc. and PerkinElmer Inc.

Key Developments:

In January 2024, BD (Becton, Dickinson and Company), a leading global medical technology company, announced a collaboration agreement with Hamilton, a leading global manufacturer of laboratory automation technology, to develop automated applications together with robotics-compatible reagent kits to enable greater standardization and reduced human error when conducting large-scale single-cell multiomics experiments.

In December 2023, Roche announced the entry into a definitive merger agreement to acquire Carmot Therapeutics, Inc. ("Carmot"), a privately owned US company based in Berkeley, California. Carmot's R&D portfolio includes clinical stage subcutaneous and oral incretins with best-in-class potential to treat obesity in patients with and without diabetes, as well as a number of preclinical programs.

In August 2023, Cognex Corporation, a leader in industrial machine vision, announced it has agreed to acquire Moritex Corporation (Moritex) from Trustar Capital, a private equity affiliate of CITIC Capital Holdings Limited, for ¥40 billion (approximately $275 million), in an all-cash transaction. Moritex is a leading global provider of optics components with a strong presence in Japan.

Products Covered:

  • Reagents and Kits
  • Instruments
  • Data Management Software
  • Other Products

Equipments Covered:

  • Automated Plate Handler
  • Automated Liquid Handler
  • Robotic Arm
  • Automated Storage and Retrieval System
  • Analyzer
  • Other Equipments

Technologies Covered:

  • Immunoassay/ Immunochemistry
  • Clinical Chemistry
  • Hematology
  • Molecular Diagnostics
  • Microbiology
  • Coagulation And Hemostasis
  • Urinalysis
  • Other Technologies

Applications Covered:

  • Infectious Diseases
  • Diabetes
  • Drug Testing/ Pharmacogenomics
  • Autoimmune Diseases
  • Oncology
  • Cardiology
  • HIV/AIDS
  • Nephrology
  • Other Applications

End Users Covered:

  • Hospital Laboratories
  • Point-Of-Care Testing Centers
  • Academic Institutes
  • Clinical Laboratories
  • Patients
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Lab Automation For In-Vitro Diagnostic Market, By Product

  • 5.1 Introduction
  • 5.2 Reagents and Kits
  • 5.3 Instruments
  • 5.4 Data Management Software
  • 5.5 Other Products

6 Global Lab Automation For In-Vitro Diagnostic Market, By Equipment

  • 6.1 Introduction
  • 6.2 Automated Plate Handler
  • 6.3 Automated Liquid Handler
  • 6.4 Robotic Arm
  • 6.5 Automated Storage and Retrieval System
  • 6.6 Analyzer
  • 6.7 Other Equipments

7 Global Lab Automation For In-Vitro Diagnostic Market, By Technology

  • 7.1 Introduction
  • 7.2 Immunoassay/ Immunochemistry
  • 7.3 Clinical Chemistry
  • 7.4 Hematology
  • 7.5 Molecular Diagnostics
  • 7.6 Microbiology
  • 7.7 Coagulation And Hemostasis
  • 7.8 Urinalysis
  • 7.9 Other Technologies

8 Global Lab Automation For In-Vitro Diagnostic Market, By Application

  • 8.1 Introduction
  • 8.2 Infectious Diseases
  • 8.3 Diabetes
  • 8.4 Drug Testing/ Pharmacogenomics
  • 8.5 Autoimmune Diseases
  • 8.6 Oncology
  • 8.7 Cardiology
  • 8.8 HIV/AIDS
  • 8.9 Nephrology
  • 8.10 Other Applications

9 Global Lab Automation For In-Vitro Diagnostic Market, By End User

  • 9.1 Introduction
  • 9.2 Hospital Laboratories
  • 9.3 Point-Of-Care Testing Centers
  • 9.4 Academic Institutes
  • 9.5 Clinical Laboratories
  • 9.6 Patients
  • 9.7 Other End Users

10 Global Lab Automation For In-Vitro Diagnostic Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 F. Hoffmann-La Roche Ltd
  • 12.2 Becton, Dickinson and Company
  • 12.3 Cognex Corporation
  • 12.4 Quidel Corporation
  • 12.5 Abbott Laboratories
  • 12.6 Siemens Healthineers AG
  • 12.7 Thermo Fisher Scientific Inc.
  • 12.8 Chembio Diagnostics, Inc
  • 12.9 Bio-Rad Laboratories, Inc.
  • 12.10 Surmodics, Inc.
  • 12.11 Danaher Corporation
  • 12.12 Tecan Group Ltd
  • 12.13 Sysmex Corporation
  • 12.14 Agilent Technologies Inc.
  • 12.15 PerkinElmer Inc.

List of Tables

  • Table 1 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Reagents and Kits (2022-2030) ($MN)
  • Table 4 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 5 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Data Management Software (2022-2030) ($MN)
  • Table 6 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 7 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Equipment (2022-2030) ($MN)
  • Table 8 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Automated Plate Handler (2022-2030) ($MN)
  • Table 9 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Automated Liquid Handler (2022-2030) ($MN)
  • Table 10 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Robotic Arm (2022-2030) ($MN)
  • Table 11 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Automated Storage and Retrieval System (2022-2030) ($MN)
  • Table 12 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Analyzer (2022-2030) ($MN)
  • Table 13 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other Equipments (2022-2030) ($MN)
  • Table 14 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Technology (2022-2030) ($MN)
  • Table 15 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Immunoassay/ Immunochemistry (2022-2030) ($MN)
  • Table 16 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Clinical Chemistry (2022-2030) ($MN)
  • Table 17 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Hematology (2022-2030) ($MN)
  • Table 18 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Molecular Diagnostics (2022-2030) ($MN)
  • Table 19 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Microbiology (2022-2030) ($MN)
  • Table 20 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Coagulation And Hemostasis (2022-2030) ($MN)
  • Table 21 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Urinalysis (2022-2030) ($MN)
  • Table 22 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 23 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Application (2022-2030) ($MN)
  • Table 24 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Infectious Diseases (2022-2030) ($MN)
  • Table 25 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Diabetes (2022-2030) ($MN)
  • Table 26 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Drug Testing/ Pharmacogenomics (2022-2030) ($MN)
  • Table 27 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Autoimmune Diseases (2022-2030) ($MN)
  • Table 28 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Oncology (2022-2030) ($MN)
  • Table 29 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Cardiology (2022-2030) ($MN)
  • Table 30 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By HIV/AIDS (2022-2030) ($MN)
  • Table 31 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Nephrology (2022-2030) ($MN)
  • Table 32 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 33 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By End User (2022-2030) ($MN)
  • Table 34 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Hospital Laboratories (2022-2030) ($MN)
  • Table 35 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Point-Of-Care Testing Centers (2022-2030) ($MN)
  • Table 36 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Academic Institutes (2022-2030) ($MN)
  • Table 37 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Clinical Laboratories (2022-2030) ($MN)
  • Table 38 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Patients (2022-2030) ($MN)
  • Table 39 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.